PALO ALTO, Calif. and MIAMI, July 20, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (âPasitheaâ or the âCompanyâ), a biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders, today confirmed that an independent special committee (âSpecial Committeeâ) of its…Read More
Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery Inc
